Mark Coleman - 20 May 2025 Form 4 Insider Report for Axsome Therapeutics, Inc. (AXSM)

Role
Director
Signature
/s/ Herriot Tabuteau, M.D., Attorney-in-Fact
Issuer symbol
AXSM
Transactions as of
20 May 2025
Net transactions value
-$322,473
Form type
4
Filing time
20 May 2025, 21:46:49 UTC
Previous filing
06 Jan 2025
Next filing
29 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Coleman Mark Director C/O AXSOME THERAPEUTICS, INC., ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK /s/ Herriot Tabuteau, M.D., Attorney-in-Fact 20 May 2025 0001658379

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXSM Common Stock Sale $322,473 -3,000 -5.3% $107.49 54,137 20 May 2025 Direct F1, F2
holding AXSM Common Stock 403,856 20 May 2025 See Footnote F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the sale of underlying shares of previously exercised stock options.
F2 Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $107.34 and $107.65.
F3 Such shares are held by an entity, of which the reporting person has voting and dispositive power, and therefore, the reporting person is deemed to be the indirect beneficial owner of such shares.